This resubmitted application requests renewed NIH support for the predoctoral Columbia University Graduate Training Program in Microbiology and Immunology. Support is requested for four training grant positions each year, as per the previous cycle. Our PhD granting program provides predoctoral trainees with a unique opportunity to obtain individualized training within a broad yet cohesive program of scientific inquiry into the immune system, host response to infection, pathogen biology, systems approaches to microbiology and immunology, cancer immunology, human immunology, transplantation, and processes of microbial and immune cell replication. Extending beyond traditional boundaries that separate microbiology and immunology, our research interests converge on three cross-disciplinary themes: i) immune cell and tissue development and homeostasis, including a major emphasis on human immunology; ii) pathogen biology and host response; and iii) DNA replication and repair and their links to cell proliferation, including cancerous processes affecting the immune system. Our 23 preceptors, with primary appointments in basic science or medical departments at the Columbia University Irving Medical Center (CUIMC), demonstrate outstanding research and training records. Most preceptors are appointed to the Department of Microbiology and Immunology, which administers this program. Trainees take courses in microbiology and immunology, molecular genetics, biochemistry, cell biology, computational and quantitative biology, and responsible conduct in research. Students also enroll in workshops on scientific writing, grant preparation, and critiquing. Trainees must also pass a qualifying examination that tests their ability to formulate and defend a hypothesis-driven project. Our graduate program is led by our Director Dr. David Fidock and Associate Director Dr. Uttiya Basu. Our programmatic framework includes an Advisory Committee that regularly evaluates student and trainer performance, the curriculum, and Training Grant Eligible applicants; a mentoring plan for junior trainers; and an External Review Board comprised of three Program Directors who provide regular feedback to help optimize program effectiveness. In the six years since our Graduate Program was first awarded NIAID funding, we have consistently recruited an excellent cohort of students, with a mean GPA of 3.6 and an average of 21 months of full-time incoming research experience for our TGE entrants, who constituted 90% of our entrants. Underrepresented minorities, who we actively seek to recruit, comprised 17% of our cohort. Our program is flourishing, as evidenced by the exceptional publication record of past and current trainees. Over >95% of our graduates have remained in science or science-related fields. We also benefit from strong institutional support from our Dean and the Office of Graduate Affairs, as well as the many scientific, educational and career development resources at CUIMC. Our dynamic, rigorous and enriching graduate program is committed to training future leaders and innovators in microbiology and immunology research.
This competing renewal resubmission for continued NIH support of the Columbia University Graduate Training Program in Microbiology and Immunology is relevant to the public health mission of NIAID in its support of research into microbial systems and immune responses that are mounted to counter host perturbations including infection, cancer, and transplantation. Our predoctoral trainees receive a unique opportunity to obtain individualized training within a broad yet cohesive program of scientific inquiry into the immune system, host response to infection, pathogen biology, systems approaches to microbiology and immunology, cancer immunology, human immunology, and processes of microbial and immune cell replication. Our PhD program is designed to provide trainees with the skills and knowledge needed to become future innovators in microbiology and immunology and to contribute to the NIH mission to improve human health through scientific research.
| Carpenter, D J; Granot, T; Matsuoka, N et al. (2018) Human immunology studies using organ donors: Impact of clinical variations on immune parameters in tissues and circulation. Am J Transplant 18:74-88 |
| Youssef, Lyla A; Rebbaa, Abdelhadi; Pampou, Sergey et al. (2018) Increased erythrophagocytosis induces ferroptosis in red pulp macrophages in a mouse model of transfusion. Blood 131:2581-2593 |
| Mumau, Melanie D; Vanderbeck, Ashley N; Lynch, Elizabeth D et al. (2018) Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1. J Immunol 200:1078-1087 |
| Kaiser, Katherine A; Arpaia, Nicholas (2018) Glycans for good. Sci Immunol 3: |
| Miron, Michelle; Kumar, Brahma V; Meng, Wenzhao et al. (2018) Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity throughout Life. J Immunol 201:2132-2140 |
| Gordon, Claire L; Miron, Michelle; Thome, Joseph J C et al. (2017) Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection. J Exp Med 214:651-667 |
| Nish, Simone A; Zens, Kyra D; Kratchmarov, Radomir et al. (2017) CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med 214:39-47 |
| Borsotti, Chiara; Danzl, Nichole M; Nauman, Grace et al. (2017) HSC extrinsic sex-related and intrinsic autoimmune disease-related human B-cell variation is recapitulated in humanized mice. Blood Adv 1:2007-2018 |
| Youssef, Lyla A; Spitalnik, Steven L (2017) Iron: a double-edged sword. Transfusion 57:2293-2297 |
| Tan, Shulian; Li, Yang; Xia, Jinxing et al. (2017) Type 1 diabetes induction in humanized mice. Proc Natl Acad Sci U S A 114:10954-10959 |
Showing the most recent 10 out of 30 publications
